Form 8-K - Current report:
SEC Accession No. 0001117480-25-000003
Filing Date
2025-03-21
Accepted
2025-03-21 06:06:26
Documents
15
Period of Report
2025-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cmrx-20250321.htm   iXBRL 8-K 33143
2 EX-99.1 exhibit99120241231cmrxearn.htm EX-99.1 90923
6 GRAPHIC chimerixlogoa.jpg GRAPHIC 13737
  Complete submission text file 0001117480-25-000003.txt   272934

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20250321.xsd EX-101.SCH 1785
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20250321_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20250321_pre.xml EX-101.PRE 13048
18 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20250321_htm.xml XML 2809
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 25758426
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)